The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
The WATCHMAN implant device is about the size of a quarter and shaped like a parachute. It is implanted into the heart to close off the left atrial appendage (LAA), a blind pouch of heart tissue to prevent blood clots from forming and causing a stroke.
Current procedural terminology (CPT) code 33340 is used to bill for the procedure to place the WATCHMAN device.
LAAO (Watchman Device) for Atrial Fibrillation The Left Atrial Appendage Occlusion Implant (LAAO) procedure is an effective way to reduce stroke risk in patients diagnosed with atrial fibrillation. Atrial fibrillation is a common cardiac condition that the effects tens of millions of people in the United States.
The left atrial appendage occlusion/Watchman procedure is among the newest surgical procedures available to prevent A-fib-related stroke.
The WATCHMAN procedure is designated by Medicare as an inpatient only procedure. Therefore, no C- code is assigned to the WATCHMAN Device. C-codes are reported for device-intensive procedures performed in the outpatient hospital site of service.
CPT® Code 93312 in section: Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording)
The WATCHMAN Left Atrial Appendage Closure Device with Delivery System (WATCHMAN device) and WATCHMAN FLX Left Atrial Appendage Closure Device with Delivery System (WATCHMAN FLX device) are permanently implanted devices intended to prevent blood clots in the left atrial appendage (LAA) from entering the bloodstream.
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The device mechanically occludes the LAA to prevent LAA thrombus from entering the systemic circulation.
New Tools in the Fight Against Heart Disease At Washington Health System, new procedures known as TAVR and WATCHMAN, open the door to less invasive surgical methods and improved outcomes for aortic valve stenosis and atrial fibrillation.
Apixaban (Eliquis) was the safest, followed by edoxaban (Savaysa), dabigatran (Pradaxa), warfarin (Coumadin) and then rivaroxaban (Xarelto); the Watchman device ranked last. The Watchman device has been advertised heavily, both to the public, in medical journals, and at medical conferences.
Eligible patients must: Have an increased risk for stroke and be recommended for anticoagulation (CHA2DS2-VASc ≥ 2 for men, ≥ 3 for women)* Be suitable for short-term oral anticoagulation. Have an appropriate reason to seek a non-pharmacologic alternative to OACs.
The WATCHMAN device is implanted in the hospital. The procedure takes about one hour, requires general anesthesia, and involves an overnight stay. See more details about what happens in the hospital on pages 7–9. When you are asleep, a flexible tube called a catheter is inserted into a vein in your upper leg.
It is correct that a successful insertion of a Watchman device into the left atrial appendage would be assigned code 02L73DK, Occlusion of left atrial appendage with intraluminal device, percutaneous approach.
AHA CODING CLINIC® FOR ICD-10-CM and ICD-10-PCS 2018 is copyrighted by the American Hospital Association ("AHA"), Chicago, Illinois. No portion of AHA CODING CLINIC® FOR ICD-10-CM and ICD-10-PCS may be reproduced, sorted in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior express, written consent of the AHA.
• The LAA anatomy will not accommodate a device. See Table 47 (in the DFU). • Any of the customary contraindications for other percutaneous catheterization procedures (e.g., patient size too small to accommodate TEE probe or required catheters) or conditions (e.g., active infection, bleeding disorder) are present. • There are contraindications to the use of warfarin, aspirin, or clopidogrel. • The patient has a known hypersensitivity to any portion of the device material or the individual components (see Device Description section) such that the use of the WATCHMAN device is contraindicated.
WATCHMAN Device is indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular atrial fibrillation who: • Are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores and are recommended for anticoagulation therapy; • Are deemed by their physicians to be suitable for warfarin; and • Have an appropriate rationale to seek a non-pharmacologic alternative to warfarin, taking into account the safety and effectiveness of the device compared to warfarin.
CPT Code + Modifier Description 33340-62 Left atrial appendage closure can be billed by two surgeons by appending the -62 modifier to 33340 (eg. 33340-62).
Computed Tomography (CT) — Baseline and Follow-Up
For questions regarding WATCHMAN™ reimbursement, please contact: Email: [email protected] Please go to www.watchmandownloadcenter.com for additional resources. The FDA Approved the WATCHMANTMon March 13, 2015 and on July 21, 2020 they approved WATCHMAN FLXTM
Updates to ICD-10-CM diagnosis codes related to Atrial Fibrillation were announced in the FY 2020 IPPS Final Rule and were effective as of October 1, 2019. Updates are described in CMS 2382, change reques t #114 91.
Medicaid plans vary with respect to their coverage of the WATCHMAN LAAC Therapy. You may contact the Boston Scientific Reimbursement Support Line for information regarding state-specific coverage status. Please contact: [email protected]
Inpatient services are assigned to Medicare Severity Diagnosis Related Groups (MS-DRGs) for payment. Based on the inpatient ICD-10-PCS code (02L73DK) and the most typical diagnosis of atrial fibrillation, WATCHMAN procedures will likely map to MS-DRG 273 or 274. This assignment is representative of percutaneous intracardiac procedures such as WATCHMAN LAAC implants, cardiac surgical ablations, and transcatheter mitral valve replacement procedures. .
Effective January 1, 2017, physicians will report the WATCHMAN implant procedure using the CPT Code 33340. The work relative value unit (RVU) for this code is 14.00 with a total RVU of 23.22. The global period for this code is 0 days.
Transesophageal echocardiography (TEE) plays a critical role in visualization and assisting with appropriate candidacy for the WATCHMAN Device. Based on our Directions for Use, the WATCHMAN procedure involves use of TEE imaging as follows:
The code used by physicians to report left atrial appendage closure with implant procedures is 33340. This code has a total RVU value of 23.22 with a work RVU of 14.0, This RVU value correlates to a national average physician payment of approximately $833.
The WATCHMAN procedure is designated by Medicare as an inpatient only procedure. Therefore, no C- code is assigned to the WATCHMAN Device. C-codes are reported for device-intensive procedures performed in the outpatient hospital site of service.
Inpatient services are assigned to Medicare Severity Diagnosis Related Groups (MS-DRGs) for payment. Based on the inpatient ICD-10-PCS code (02L73DK) and the most typical diagnosis of atrial fibrillation, WATCHMAN procedures will likely map to MS-DRG 273 or 274. This assignment is representative of percutaneous intracardiac procedures such as WATCHMAN LAAC implants, cardiac surgical ablations, and transcatheter mitral valve replacement procedures. .
Effective January 1, 2017, physicians will report the WATCHMAN implant procedure using the CPT Code 33340. The work relative value unit (RVU) for this code is 14.00 with a total RVU of 23.22. The global period for this code is 0 days.
Transesophageal echocardiography (TEE) plays a critical role in visualization and assisting with appropriate candidacy for the WATCHMAN Device. Based on our Directions for Use, the WATCHMAN procedure involves use of TEE imaging as follows:
The code used by physicians to report left atrial appendage closure with implant procedures is 33340. This code has a total RVU value of 23.22 with a work RVU of 14.0, This RVU value correlates to a national average physician payment of approximately $833.
The WATCHMAN procedure is designated by Medicare as an inpatient only procedure. Therefore, no C- code is assigned to the WATCHMAN Device. C-codes are reported for device-intensive procedures performed in the outpatient hospital site of service.
CPT copyright 2016 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors, and/or related components are not assigned by the AMA, are not part of CPT®, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
The 2022 edition of ICD-10-CM Z95.818 became effective on October 1, 2021.
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status
In this case, you should only code the root operation that was performed. The correct ICD-10-PCS code for this procedure is BB4BZZZ Ultrasonography of pleura .
The correct ICD-10-PCS code for this procedure is 037H0ZZ Dilation of common carotid artery, open approach.
In the inpatient coding world, a great deal of importance is placed on coding to derive the correct diagnosis-related group (DRG) assignment. As coders, part of our responsibility is to review medical record documentation. We must verify whether a procedure was performed as planned and code accordingly, as this ultimately impacts Medicare severity diagnosis-related groups (MS-DRGs) and reimbursement.
A discontinued procedure is one that is canceled or not fully accomplished under the procedure definition. To determine if a procedure was discontinued, look for the following key terms in the documentation: